• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Early-stage

EQT Ventures leads $41m round for Small Giant Games
EQT Ventures leads $41m round for Small Giant Games

Participants in the round include existing investors Creandum, Spintop Ventures and Profounders

  • Early-stage
  • 21 February 2018
Pontifax backs €16m series-A funding round for Abac Therapeutics
Pontifax backs €16m series-A funding round for Abac Therapeutics

Backers include Global Health Science Fund, Caixa Capital Risc and Debiopharm Innovation Fund

  • Early-stage
  • 19 February 2018
Alliance backs Boost AI in $5m funding round
Alliance backs Boost AI in $5m funding round

Financing will be used to strengthen technical and commercial teams for expansion plans

  • Early-stage
  • 16 February 2018
Ascend Capital backs TactoTek in $23m round
Ascend Capital backs TactoTek in $23m round

TactoTek will use the fresh capital to expand operations and production capacity

  • Early-stage
  • 16 February 2018
Inception leads €2.2m seed round for Penta
Inception leads €2.2m seed round for Penta

Fresh capital will be used to hire more staff to support the company's growing customer base

  • Early-stage
  • 05 February 2018
Parkwalk leads £6m series-A for Bodle Technologies
Parkwalk leads £6m series-A for Bodle Technologies

Low-powered video display producer will use the funding to scale up its operations

  • Early-stage
  • 30 January 2018
Go Capital et al. invest in Pherecydes Pharma
Go Capital et al. invest in Pherecydes Pharma

New backers include Omnes Capital, Fa Dièse and a group of angel investors

  • Early-stage
  • 26 January 2018
Nauta leads $5m round for Onna
Nauta leads $5m round for Onna

Software firm intends to make key senior hires, develop its product, and expand internationally

  • Early-stage
  • 24 January 2018
Xerys leads €14m series-B for AlzProtect
Xerys leads €14m series-B for AlzProtect

Xerys is now the main financial investor in the company following the latest funding round

  • Early-stage
  • 23 January 2018
Omnes Capital et al. in $1.7m series-A round for Vsora
Omnes Capital et al. in $1.7m series-A round for Vsora

Omnes Capital, Partech Ventures and angel investors back the French DSP IP provider

  • Early-stage
  • 18 January 2018
BPI France et al. in €18.5m series-B round for HalioDX
BPI France et al. in €18.5m series-B round for HalioDX

French tumour microenvironment diagnostics expert is backed by a consortium of investors

  • Early-stage
  • 17 January 2018
Sequoia, Google Ventures lead £20m series-A for Vaccitech
Sequoia, Google Ventures lead £20m series-A for Vaccitech

Neptune Ventures also takes part in the financing, bringing the total raised to ТЃ30m

  • Early-stage
  • 17 January 2018
Intel, Investinor lead $12.5m series-B for Swarm64
Intel, Investinor lead $12.5m series-B for Swarm64

Previous Investors Alliance Venture and Target Partners also take part in the round

  • Early-stage
  • 08 January 2018
Prime Ventures leads $38m series-C for AImotive
Prime Ventures leads $38m series-C for AImotive

Other backers in the round include Cisco Investments, Samsung Catalyst Fund and Inventure

  • Early-stage
  • 05 January 2018
Ming et al. in €25m series-D round for Miracor Medical
Ming et al. in €25m series-D round for Miracor Medical

Belgian public investors SFPI, SRIW and Meusinvest grant a non-dilutive cash advance

  • Early-stage
  • 05 January 2018
VC firms inject CHF 20m into Oculis
VC firms inject CHF 20m into Oculis

Company simultaneously announces the relocation of its headquarters from Reykjavik to Lausanne

  • Early-stage
  • 05 January 2018
Principia et al. in €32m series-D round for Enterome
Principia et al. in €32m series-D round for Enterome

Company also nets a €40m credit line provided by the European Investment Bank

  • Early-stage
  • 04 January 2018
Funds back $270m series-A for BioNTech
Funds back $270m series-A for BioNTech

Struengmann Family Office commits fresh capital to the round and retains a majority stake

  • Early-stage
  • 04 January 2018
VC firms in £85m series-B for Orchard Therapeutics
VC firms in £85m series-B for Orchard Therapeutics

Fresh capital will be used for the global launch of the company's lead gene therapy product

  • Early-stage
  • 21 December 2017
Accel leads $20m series-B for Instana
Accel leads $20m series-B for Instana

Latest funding round with Target Partners brings the company's total funding to $27m

  • Early-stage
  • 14 December 2017
Forbion, BGV lead €25m series-A for NorthSea Therapeutics
Forbion, BGV lead €25m series-A for NorthSea Therapeutics

Fresh capital will be used to conduct a phase IIb clinical study in preparation for phase III

  • Early-stage
  • 14 December 2017
Saudi Aramco et al. in €8m round for Nexwafe
Saudi Aramco et al. in €8m round for Nexwafe

German family office Wermuth Asset Management has also taken part alongside GGF2 and Lynwood

  • Early-stage
  • 12 December 2017
VC firms in $59.6m series-C for Hookipa
VC firms in $59.6m series-C for Hookipa

New investors include HB Partners, Hillhouse Capital, Sirona Capital and Gilead Sciences

  • Early-stage
  • 12 December 2017
HPE leads $19m series-C for NG Data
HPE leads $19m series-C for NG Data

Other backers include Idinvest, Pamica, SmartFin, Capricorn and Nausicaa Ventures

  • Early-stage
  • 07 December 2017
151617
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013